IVD Market Size, Share, and Outlook, H2-2025 Report- By Product and Services (Reagents & Kits, Services, Instruments, Data Management Software), By Application (Infectious diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune diseases, Oncology,
Description
IVD Market Outlook
The global IVD Market Size is valued at $114.2 Billion in 2025 and is forecast to reach $194.5 Billion in 2032 at a CAGR of 7.9%.
The IVD Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on IVD Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product and Services (Reagents & Kits, Services, Instruments, Data Management Software), By Application (Infectious diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune diseases, Oncology, Cardiology, HIV/AIDS, Nephrology, Others), By Technology (Immunoassay/ Immunochemistry, Clinical chemistry, Hematology, Molecular diagnostics, Microbiology, Coagulation and Hemostasis, Urinalysis, Others), By End-User (Hospital laboratories, Point-of-care testing centers, Academic institutes, Clinical laboratories, Patients, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
IVD Market Insights, 2025
The in vitro diagnostics (IVD) market is poised for significant growth in 2025, driven by the convergence of technological innovation, personalized medicine, and rising demand for early disease detection. Diagnostic technologies are becoming increasingly sophisticated, with molecular diagnostics, point-of-care testing, and next-generation sequencing reshaping how clinicians identify and monitor conditions. The COVID-19 pandemic accelerated adoption of rapid testing, leaving behind a permanent shift in both healthcare infrastructure and consumer expectations for accessible diagnostics. Additionally, aging populations and rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer continue to expand testing needs worldwide. Digitalization and AI-driven diagnostic platforms are streamlining data interpretation, creating opportunities for precision care and value-based healthcare models. However, challenges such as regulatory hurdles, reimbursement complexities, and disparities in access across emerging markets remain. Strategic partnerships between diagnostics companies, biopharma, and digital health firms are further catalyzing innovation pipelines. By 2025, the IVD market is not only a cornerstone of healthcare delivery but also a critical enabler of predictive, preventive, and personalized medicine.
Five Trends Shaping the Global IVD Market in 2025 and Beyond
The global IVD Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the IVD Industry?
The IVD Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, IVD Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
IVD Market Segment Insights
The IVD Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product and Services (Reagents & Kits, Services, Instruments, Data Management Software), By Application (Infectious diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune diseases, Oncology, Cardiology, HIV/AIDS, Nephrology, Others), By Technology (Immunoassay/ Immunochemistry, Clinical chemistry, Hematology, Molecular diagnostics, Microbiology, Coagulation and Hemostasis, Urinalysis, Others), By End-User (Hospital laboratories, Point-of-care testing centers, Academic institutes, Clinical laboratories, Patients, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
IVD Industry Value Chain
The chapter identifies potential companies and their operations across the global IVD Industry ecosystem. It assists decision-makers in evaluating global IVD Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the IVD Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific IVD Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for IVD Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States IVD Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American IVD Market.
Europe IVD Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for IVD Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for IVD Industry competitiveness. The report analyses the key IVD Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American IVD Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international IVD Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa IVD Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for IVD Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How IVD Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the IVD Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Accelerate Diagnostics Inc, Agilent Technologies Inc, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Caris Life Sciences Inc, Chembio Diagnostics Inc , Danaher Corp, Devyser, DiaSorin S.p.A, GENSPEED Biotech GmbH, Hologic Inc, Illumina Inc, Menarini Silicon Biosystems, Merck KGaA, PerkinElmer Inc, QIAGEN N.V., Quidel Corp, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, SpeeDx Pty. Ltd, Surmodics Inc, Sysmex Corp, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
IVD Market Scope
Leading Segments
By Product and Service
Reagents & Kits
Services
Instruments
Data Management Software
By Application
Infectious diseases
Diabetes
Drug Testing/ Pharmacogenomics
Autoimmune diseases
Oncology
Cardiology
HIV/AIDS
Nephrology
Others
By Technology
Immunoassay/ Immunochemistry
Clinical chemistry
Hematology
Molecular diagnostics
Microbiology
Coagulation and Hemostasis
Urinalysis
Others
By End-User
Hospital laboratories
Point-of-care testing centers
Academic institutes
Clinical laboratories
Patients
Others
Leading Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Agilent Technologies Inc
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
Caris Life Sciences Inc
Chembio Diagnostics Inc
Danaher Corp
Devyser
DiaSorin S.p.A
GENSPEED Biotech GmbH
Hologic Inc
Illumina Inc
Menarini Silicon Biosystems
Merck KGaA
PerkinElmer Inc
QIAGEN N.V.
Quidel Corp
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
SpeeDx Pty. Ltd
Surmodics Inc
Sysmex Corp
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global IVD Market Size is valued at $114.2 Billion in 2025 and is forecast to reach $194.5 Billion in 2032 at a CAGR of 7.9%.
The IVD Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on IVD Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product and Services (Reagents & Kits, Services, Instruments, Data Management Software), By Application (Infectious diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune diseases, Oncology, Cardiology, HIV/AIDS, Nephrology, Others), By Technology (Immunoassay/ Immunochemistry, Clinical chemistry, Hematology, Molecular diagnostics, Microbiology, Coagulation and Hemostasis, Urinalysis, Others), By End-User (Hospital laboratories, Point-of-care testing centers, Academic institutes, Clinical laboratories, Patients, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
IVD Market Insights, 2025
The in vitro diagnostics (IVD) market is poised for significant growth in 2025, driven by the convergence of technological innovation, personalized medicine, and rising demand for early disease detection. Diagnostic technologies are becoming increasingly sophisticated, with molecular diagnostics, point-of-care testing, and next-generation sequencing reshaping how clinicians identify and monitor conditions. The COVID-19 pandemic accelerated adoption of rapid testing, leaving behind a permanent shift in both healthcare infrastructure and consumer expectations for accessible diagnostics. Additionally, aging populations and rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer continue to expand testing needs worldwide. Digitalization and AI-driven diagnostic platforms are streamlining data interpretation, creating opportunities for precision care and value-based healthcare models. However, challenges such as regulatory hurdles, reimbursement complexities, and disparities in access across emerging markets remain. Strategic partnerships between diagnostics companies, biopharma, and digital health firms are further catalyzing innovation pipelines. By 2025, the IVD market is not only a cornerstone of healthcare delivery but also a critical enabler of predictive, preventive, and personalized medicine.
Five Trends Shaping the Global IVD Market in 2025 and Beyond
The global IVD Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the IVD Industry?
The IVD Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, IVD Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
IVD Market Segment Insights
The IVD Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product and Services (Reagents & Kits, Services, Instruments, Data Management Software), By Application (Infectious diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune diseases, Oncology, Cardiology, HIV/AIDS, Nephrology, Others), By Technology (Immunoassay/ Immunochemistry, Clinical chemistry, Hematology, Molecular diagnostics, Microbiology, Coagulation and Hemostasis, Urinalysis, Others), By End-User (Hospital laboratories, Point-of-care testing centers, Academic institutes, Clinical laboratories, Patients, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
IVD Industry Value Chain
The chapter identifies potential companies and their operations across the global IVD Industry ecosystem. It assists decision-makers in evaluating global IVD Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the IVD Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific IVD Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for IVD Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States IVD Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American IVD Market.
Europe IVD Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for IVD Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for IVD Industry competitiveness. The report analyses the key IVD Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American IVD Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international IVD Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa IVD Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for IVD Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How IVD Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the IVD Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Accelerate Diagnostics Inc, Agilent Technologies Inc, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Caris Life Sciences Inc, Chembio Diagnostics Inc , Danaher Corp, Devyser, DiaSorin S.p.A, GENSPEED Biotech GmbH, Hologic Inc, Illumina Inc, Menarini Silicon Biosystems, Merck KGaA, PerkinElmer Inc, QIAGEN N.V., Quidel Corp, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, SpeeDx Pty. Ltd, Surmodics Inc, Sysmex Corp, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
IVD Market Scope
Leading Segments
By Product and Service
Reagents & Kits
Services
Instruments
Data Management Software
By Application
Infectious diseases
Diabetes
Drug Testing/ Pharmacogenomics
Autoimmune diseases
Oncology
Cardiology
HIV/AIDS
Nephrology
Others
By Technology
Immunoassay/ Immunochemistry
Clinical chemistry
Hematology
Molecular diagnostics
Microbiology
Coagulation and Hemostasis
Urinalysis
Others
By End-User
Hospital laboratories
Point-of-care testing centers
Academic institutes
Clinical laboratories
Patients
Others
Leading Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Agilent Technologies Inc
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
Caris Life Sciences Inc
Chembio Diagnostics Inc
Danaher Corp
Devyser
DiaSorin S.p.A
GENSPEED Biotech GmbH
Hologic Inc
Illumina Inc
Menarini Silicon Biosystems
Merck KGaA
PerkinElmer Inc
QIAGEN N.V.
Quidel Corp
F. Hoffmann-La Roche Ltd
Siemens Healthineers AG
SpeeDx Pty. Ltd
Surmodics Inc
Sysmex Corp
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
194 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 IVD Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest IVD Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global IVD Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 IVD Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. IVD Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product and Service
- Reagents & Kits
- Services
- Instruments
- Data Management Software
- By Application
- Infectious diseases
- Diabetes
- Drug Testing/ Pharmacogenomics
- Autoimmune diseases
- Oncology
- Cardiology
- HIV/AIDS
- Nephrology
- Others
- By Technology
- Immunoassay/ Immunochemistry
- Clinical chemistry
- Hematology
- Molecular diagnostics
- Microbiology
- Coagulation and Hemostasis
- Urinalysis
- Others
- By End-User
- Hospital laboratories
- Point-of-care testing centers
- Academic institutes
- Clinical laboratories
- Patients
- Others
- 6. Global IVD Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America IVD Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America IVD Market Trends and Growth Opportunities
- 6.2.1 North America IVD Market Outlook by Type
- 6.2.2 North America IVD Market Outlook by Application
- 6.3 North America IVD Market Outlook by Country
- 6.3.1 The US IVD Market Outlook, 2021- 2032
- 6.3.2 Canada IVD Market Outlook, 2021- 2032
- 6.3.3 Mexico IVD Market Outlook, 2021- 2032
- 7. Europe IVD Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe IVD Market Trends and Growth Opportunities
- 7.2.1 Europe IVD Market Outlook by Type
- 7.2.2 Europe IVD Market Outlook by Application
- 7.3 Europe IVD Market Outlook by Country
- 7.3.2 Germany IVD Market Outlook, 2021- 2032
- 7.3.3 France IVD Market Outlook, 2021- 2032
- 7.3.4 The UK IVD Market Outlook, 2021- 2032
- 7.3.5 Spain IVD Market Outlook, 2021- 2032
- 7.3.6 Italy IVD Market Outlook, 2021- 2032
- 7.3.7 Russia IVD Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe IVD Market Outlook, 2021- 2032
- 8. Asia Pacific IVD Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific IVD Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific IVD Market Outlook by Type
- 8.2.2 Asia Pacific IVD Market Outlook by Application
- 8.3 Asia Pacific IVD Market Outlook by Country
- 8.3.1 China IVD Market Outlook, 2021- 2032
- 8.3.2 India IVD Market Outlook, 2021- 2032
- 8.3.3 Japan IVD Market Outlook, 2021- 2032
- 8.3.4 South Korea IVD Market Outlook, 2021- 2032
- 8.3.5 Australia IVD Market Outlook, 2021- 2032
- 8.3.6 South East Asia IVD Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific IVD Market Outlook, 2021- 2032
- 9. South America IVD Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America IVD Market Trends and Growth Opportunities
- 9.2.1 South America IVD Market Outlook by Type
- 9.2.2 South America IVD Market Outlook by Application
- 9.3 South America IVD Market Outlook by Country
- 9.3.1 Brazil IVD Market Outlook, 2021- 2032
- 9.3.2 Argentina IVD Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America IVD Market Outlook, 2021- 2032
- 10. Middle East and Africa IVD Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa IVD Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa IVD Market Outlook by Type
- 10.2.2 Middle East and Africa IVD Market Outlook by Application
- 10.3 Middle East and Africa IVD Market Outlook by Country
- 10.3.1 Saudi Arabia IVD Market Outlook, 2021- 2032
- 10.3.2 The UAE IVD Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East IVD Market Outlook, 2021- 2032
- 10.3.4 South Africa IVD Market Outlook, 2021- 2032
- 10.3.5 Egypt IVD Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa IVD Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Accelerate Diagnostics Inc
- Agilent Technologies Inc
- Becton, Dickinson and Company
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Caris Life Sciences Inc
- Chembio Diagnostics Inc
- Danaher Corp
- Devyser
- DiaSorin S.p.A
- GENSPEED Biotech GmbH
- Hologic Inc
- Illumina Inc
- Menarini Silicon Biosystems
- Merck KGaA
- PerkinElmer Inc
- QIAGEN N.V.
- Quidel Corp
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
- SpeeDx Pty. Ltd
- Surmodics Inc
- Sysmex Corp
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
